The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Use of lipid-lowering drugs in patients with cancer.
Edgardo G. J. Rivarola
No relevant relationships to disclose
Ernesto Gil Deza
No relevant relationships to disclose
Gabriel Lebersztein
No relevant relationships to disclose
Eduardo L. Morgenfeld
No relevant relationships to disclose
Carlos Fernando Garcia Gerardi
No relevant relationships to disclose
Felipe G. Gercovich
No relevant relationships to disclose